Gennova Biopharmaceuticals expands CEPI partnership for Nipah virus saRNA vaccine development
Gennova secures $13.38 million from CEPI to advance self-amplifying mRNA vaccine for Nipah virus
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
vaccine
Novavax reaches settlement with UK Health Security Agency over COVID-19 vaccine agreement
Novavax to refund $123.8 million to UKHSA in quarterly payments through 2027
Pfizer’s ABRYSVO RSV vaccine approved by FDA for broader adult use
The vaccine is now approved for adults aged 18 to 59 at higher risk of RSV-related respiratory illness, expanding its prior…
Indian Immunologicals partners with ICMR for clinical development of India’s first Zika vaccine
Agreement signed for Phase I trials of codon de-optimized live attenuated Zika vaccine, funded by ICMR
British drugmaker GSK moves mRNA flu vaccine to late-stage trials
Positive mid-stage trial results push GSK's mRNA flu vaccine towards late-stage clinical development, showing enhanced immune…
GSK’s experimental herpes vaccine fails to meet main goal in trial
GSK’s experimental herpes vaccine misses trial target, but study continues for safety monitoring and insights into recurrent…
rVSV-ZEBOV vaccine first real-world data support prophylactic use for future Ebola outbreaks:…
Real-world data show rVSV-ZEBOV vaccine is 84 per cent effective against Ebola, supporting its use in future outbreaks
Bharat Biotech launches oral cholera vaccine HILLCHOL to address global shortage
New manufacturing facilities aim to bridge critical vaccine supply gap
IIL develops needle-free intranasal COVID-19 booster vaccine
New vaccine developed in collaboration with Griffith University published in ‘Nature Communications’
Pfizer’s RSV vaccine shows benefit in immuno-compromised adults in study
In a late-stage study, Pfizer’s Abrysvo vaccine generated robust antibodies against RSV-A and RSV-B in immunocompromised adults,…